{
    "organizations": [],
    "uuid": "6d645be95029fcccdd57c5e038288f4fd84fc3cc",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-cspc-pharmaceutical-announces-a-pr/brief-cspc-pharmaceutical-announces-a-product-licensing-agreement-idUSFWN1RV0EA",
    "ord_in_thread": 0,
    "title": "BRIEF-CSPC Pharmaceutical Announces A Product Licensing Agreement",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 18 (Reuters) - CSPC Pharmaceutical Group Ltd :\n* UNIT ENTERED PRODUCT LICENSING AGREEMENT WITH GALAXY BIO, INC. FOR LICENSING & COMMERCIALIZATION OF “PACLITAXEL FOR INJECTION”\n* GALAXY BIO TO PAY PRESCRIBED PCT OF NET PROFIT OF PRODUCT IN TERRITORY TO UNIT AS SALES ROYALTY DURING 20 YEAR TERM Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-18T19:20:00.000+03:00",
    "crawled": "2018-04-19T15:08:23.007+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "cspc",
        "pharmaceutical",
        "group",
        "ltd",
        "unit",
        "entered",
        "product",
        "licensing",
        "agreement",
        "galaxy",
        "bio",
        "licensing",
        "commercialization",
        "paclitaxel",
        "injection",
        "galaxy",
        "bio",
        "pay",
        "prescribed",
        "pct",
        "net",
        "profit",
        "product",
        "territory",
        "unit",
        "sale",
        "royalty",
        "year",
        "term",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}